111 related articles for article (PubMed ID: 20691983)
1. Dose variation of hepatocyte growth factor and its effects on an animal model of TPN-induced liver injury.
Katz MS; Thatch KA; Schwartz MZ
J Surg Res; 2010 Oct; 163(2):294-8. PubMed ID: 20691983
[TBL] [Abstract][Full Text] [Related]
2. Growth factor modulation of hepatic inflammation: a novel approach to the management of total parenteral nutrition-associated liver disease.
Thatch KA; Katz MS; Haber MM; Schwartz MZ
J Pediatr Surg; 2010 Jan; 45(1):89-94. PubMed ID: 20105586
[TBL] [Abstract][Full Text] [Related]
3. Modulation of the inflammatory response and apoptosis using epidermal growth factor and hepatocyte growth factor in a liver injury model: a potential approach to the management and treatment of cholestatic liver disease.
Thatch KA; Schwartz MZ; Yoo EY; Mendelson KG; Duke DS
J Pediatr Surg; 2008 Dec; 43(12):2169-73. PubMed ID: 19040928
[TBL] [Abstract][Full Text] [Related]
4. [Effect of the administration of cholecystokinin on the cholestasis associated with total parenteral nutrition in experimental short bowel].
García-Urkia N; Asensio AB; Cano A; Samprón N; García-Arenzana JM; Bachiller P; Aldazabal P; Eizaguirre I
Cir Pediatr; 2007 Jul; 20(3):180-2. PubMed ID: 18018748
[TBL] [Abstract][Full Text] [Related]
5. Growth factor manipulation of intestinal angiogenesis: a possible new paradigm in the management of inflammatory bowel disease.
Thatch KA; Mendelson KG; Haber MM; Schwartz MZ
J Surg Res; 2009 Oct; 156(2):245-9. PubMed ID: 19524260
[TBL] [Abstract][Full Text] [Related]
6. Factor VII transcription correlates with hepatocyte proliferation and hepatocyte growth factor expression in a rodent extrahepatic portal vein obstruction model.
Chiu B; Melin-Aldana H; Pillai S; Chu F; Superina RA
J Am Coll Surg; 2007 Aug; 205(2):277-83. PubMed ID: 17660074
[TBL] [Abstract][Full Text] [Related]
7. Lack of enteral nutrition--effects on the intestinal immune system.
Wildhaber BE; Yang H; Spencer AU; Drongowski RA; Teitelbaum DH
J Surg Res; 2005 Jan; 123(1):8-16. PubMed ID: 15652945
[TBL] [Abstract][Full Text] [Related]
8. NTP toxicology and carcinogenesis studies of 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (CAS No. 57465-28-8) in female Harlan Sprague-Dawley rats (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2006 Jan; (520):4-246. PubMed ID: 16628245
[TBL] [Abstract][Full Text] [Related]
9. The preventative role of growth hormone on acute liver injury induced by cardiopulmonary bypass in a rat model.
An Y; Xiao YB
Eur J Cardiothorac Surg; 2007 Jun; 31(6):1037-43. PubMed ID: 17498965
[TBL] [Abstract][Full Text] [Related]
10. Anti-inflammatory effects of hepatocyte growth factor: induction of interleukin-1 receptor antagonist.
Molnar C; Garcia-Trevijano ER; Ludwiczek O; Talabot D; Kaser A; Mato JM; Fritsche G; Weiss G; Gabay C; Avila MA; Tilg H
Eur Cytokine Netw; 2004; 15(4):303-11. PubMed ID: 15627638
[TBL] [Abstract][Full Text] [Related]
11. Recombinant human growth hormone (rhGH) downregulates hepatocyte growth factor (HGF) in burns.
Jeschke MG; Wolf SE; DebRoy MA; Jarrar D; Herndon DN
J Surg Res; 1998 Apr; 76(1):11-6. PubMed ID: 9695731
[TBL] [Abstract][Full Text] [Related]
12. The administration of hepatocyte growth factor prevents total parenteral nutrition-induced hepatocellular injury in a rat model.
Matsukubo M; Yano K; Kaji T; Sugita K; Onishi S; Harumatsu T; Nagano A; Matsui M; Murakami M; Yamada K; Yamada W; Muto M; Kumagai K; Ido A; Ieiri S
Pediatr Surg Int; 2021 Mar; 37(3):353-361. PubMed ID: 33388954
[TBL] [Abstract][Full Text] [Related]
13. Influence of luminal hepatocyte growth factor on small intestine mucosa in vivo.
Kato Y; Yu D; Lukish JR; Schwartz MZ
J Surg Res; 1997 Jul; 71(1):49-53. PubMed ID: 9271277
[TBL] [Abstract][Full Text] [Related]
14. Oxidative injury and hepatocyte apoptosis in total parenteral nutrition-associated liver dysfunction.
Cai W; Wu J; Hong L; Xu Y; Tang Q; Shi C
J Pediatr Surg; 2006 Oct; 41(10):1663-8. PubMed ID: 17011265
[TBL] [Abstract][Full Text] [Related]
15. Erythropoietin attenuates lipopolysaccharide-induced white matter injury in the neonatal rat brain.
Kumral A; Baskin H; Yesilirmak DC; Ergur BU; Aykan S; Genc S; Genc K; Yilmaz O; Tugyan K; Giray O; Duman N; Ozkan H
Neonatology; 2007; 92(4):269-78. PubMed ID: 17627093
[TBL] [Abstract][Full Text] [Related]
16. Growth hormone prevents acute liver injury induced by cardiopulmonary bypass in a rat model.
An Y; Xiao YB
J Thorac Cardiovasc Surg; 2007 Aug; 134(2):342-50. PubMed ID: 17662771
[TBL] [Abstract][Full Text] [Related]
17. The preventive effect of recombinant human hepatocyte growth factor for hepatic steatosis in a rat model of short bowel syndrome.
Yano K; Sugita K; Muto M; Matsukubo M; Onishi S; Kedoin C; Matsui M; Murakami M; Harumatsu T; Yamada K; Yamada W; Kumagai K; Ido A; Kaji T; Ieiri S
J Pediatr Surg; 2022 Jul; 57(7):1286-1292. PubMed ID: 35396090
[TBL] [Abstract][Full Text] [Related]
18. Lethality of standard total parenteral nutrition following major liver resection in rats is prevented by high arginine and high branched chain amino acids but not by glutamine.
Qiu JG; Delany HM; Teh EL; Gliedman ML; Chang CJ; Levenson SM
J Assoc Acad Minor Phys; 2001 Mar; 12(1-2):109-18. PubMed ID: 11851195
[TBL] [Abstract][Full Text] [Related]
19. Beneficial effect of deletion variant of hepatocyte growth factor for impaired hepatic regeneration in the ischemically damaged liver.
Okamoto K; Suzuki S; Kurachi K; Sunayama K; Yokoi Y; Konno H; Baba S; Nakamura S
World J Surg; 2002 Oct; 26(10):1260-6. PubMed ID: 12205552
[TBL] [Abstract][Full Text] [Related]
20. A possible mechanism for prevention of intestinal programmed cell death after ischemia-reperfusion injury by hepatocyte growth factor pretreatment.
Kuenzler KA; Arthur LG; Schwartz MZ
J Pediatr Surg; 2002 Dec; 37(12):1696-9. PubMed ID: 12483633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
